SCHEMBL14397264

SCHEMBL14397264

C=C(CCc1ccccc1)C(=O)OCN

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.51
KEAP1 Q14145 1/20 0.48
FFAR1 O14842 4/20 0.46
ALDH1A1 P00352 2/20 0.46
LMNA P02545 1/20 0.44
HDAC2 Q92769 2/20 0.43
HDAC8 Q9BY41 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
HDAC1 Q13547 2/20 0.42
HDAC3 O15379 1/20 0.42
MAPK1 P28482 1/20 0.42
ADRA1A P35348 1/20 0.42
HDAC4 P56524 1/20 0.42
SLC6A3 Q01959 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7398418 0.85 TDP1 (0.53) TDP1KEAP1FFAR1ALDH1A1LMNA
SCHEMBL7299043 0.83 MAPT (0.53) TDP1KEAP1FFAR1ALDH1A1HDAC2
SCHEMBL3291001 0.83 KEAP1 (0.52) TDP1KEAP1FFAR1ALDH1A1LMNA
SCHEMBL9116026 0.83 ALDH1A1 (0.46) ALDH1A1LMNAHDAC8HDAC6MAPK1
SCHEMBL5704682 0.82 TDP1 (0.54) TDP1KEAP1FFAR1ALDH1A1LMNA
SCHEMBL28007941 0.80 TDP1 (0.51) TDP1KEAP1FFAR1ALDH1A1LMNA
SCHEMBL1093411 0.80 TDP1 (0.47) TDP1KEAP1FFAR1ALDH1A1HDAC2
SCHEMBL3997663 0.79 ALDH1A1 (0.53) TDP1KEAP1FFAR1ALDH1A1LMNA
SCHEMBL27488874 0.79 TDP1 (0.75) TDP1KEAP1FFAR1ALDH1A1LMNA
SCHEMBL2289190 0.78 TDP1 (0.46) TDP1KEAP1FFAR1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007111994-A2 COMPOUNDS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH ER STRESS SYNDEXA PHARMACEUTICALS CORPORATION (US) 2007-10-04 WO disclosed